Multiple Methods for Reduction of Lipoprotein(a).
Dalessandri
Kathie M
KM
D001205:Ascorbic Acid / Q000494:pharmacology / Q000627:therapeutic use; D002331:Carnitine / Q000494:pharmacology / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000209:etiology; D004038:Diet, Reducing; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D015444:Exercise; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000235:genetics; D017270:Lipoprotein(a) / Q000097:blood*; D009154:Mutation; D009525:Niacin / Q000494:pharmacology / Q000627:therapeutic use; D011973:Receptors, LDL / Q000235:genetics; D012307:Risk Factors; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use
D004967:Estrogens; D017270:Lipoprotein(a); D011973:Receptors, LDL; D013629:Tamoxifen; D009525:Niacin; D001205:Ascorbic Acid; D002331:Carnitine